Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
Dhananjay K. Kaul, … , Ronald L. Nagel, Mary E. Fabry
Dhananjay K. Kaul, … , Ronald L. Nagel, Mary E. Fabry
Published October 15, 2004
Citation Information: J Clin Invest. 2004;114(8):1136-1145. https://doi.org/10.1172/JCI21633.
View: Text | PDF
Article Vascular biology Article has an altmetric score of 1

Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice

  • Text
  • PDF
Abstract

In sickle cell disease, intravascular sickling and attendant flow abnormalities underlie the chronic inflammation and vascular endothelial abnormalities. However, the relationship between sickling and vascular tone is not well understood. We hypothesized that sickling-induced vaso-occlusive events and attendant oxidative stress will affect microvascular regulatory mechanisms. In the present studies, we have examined whether microvascular abnormalities expressed in sickle transgenic-knockout Berkeley (BERK) mice (which express exclusively human α- and βS-globins with <1% γ-globin levels) are amenable to correction with increased levels of antisickling fetal hemoglobin (HbF). In BERK mice, sickling, increased oxidative stress, and hemolytic anemia are accompanied by vasodilation, compensatory increases in eNOS and COX-2, and attenuated vascular responses to NO-mediated vasoactive stimuli and norepinephrine. The hypotension and vasodilation (required for adequate oxygen delivery in the face of chronic anemia) are mediated by non-NO vasodilators (i.e., prostacyclin) as evidenced by induction of COX-2. In BERK mice, the resistance to NO-mediated vasodilators is associated with increased oxidative stress and hemolytic rate, and in BERK + γ mice (expressing 20% HbF), an improved response to these stimuli is associated with reduced oxidative stress and hemolytic rate. Furthermore, BERK + γ mice show normalization of vessel diameters, and eNOS and COX-2 expression. These results demonstrate a strong relationship between sickling and microvascular function in sickle cell disease.

Authors

Dhananjay K. Kaul, Xiao-du Liu, Hee-Yoon Chang, Ronald L. Nagel, Mary E. Fabry

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2018 2017 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 Total
Citations: 1 1 1 1 1 1 3 2 4 7 2 3 2 9 3 4 3 48
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (48)

Title and authors Publication Year
Soluble guanylate cyclase stimulators and activators: new horizons in the treatment of priapism associated with sickle cell disease
Pereira DA, Silveira TH, Calmasini FB, Silva FH
Frontiers in pharmacology 2024
Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
Chiang KC, Gupta A, Sundd P, Krishnamurti L
Biomedicines 2023
Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease
Sargur Madabushi S, Fouda R, Ghimire H, Abdelhamid AM, Lim JE, Vishwasrao P, Kiven S, Brooks J, Zuro D, Rosenthal J, Guha C, Gupta K, Hui SK
Frontiers in Oncology 2022
PPARγ increases HUWE1 to attenuate NF-κB/p65 and sickle cell disease with pulmonary hypertension
AJ Jang, SS Chang, C Park, CM Lee, RL Benza, MJ Passineau, J Ma, DR Archer, RL Sutliff, CM Hart, BY Kang
Blood Advances 2021
The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease
Ballas SK
Mediterranean journal of hematology and infectious diseases 2020
Nitric Oxide–Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease
KP Potoka, KC Wood, JJ Baust, M Bueno, SA Hahn, RR Vanderpool, T Bachman, GM Mallampalli, DO Osei-Hwedieh, V Schrott, B Sun, GC Bullock, EM Becker-Pelster, M Wittwer, J Stampfuss, I Mathar, JP Stasch, H Truebel, P Sandner, AL Mora, AC Straub, MT Gladwin
American journal of respiratory cell and molecular biology 2018
Hemolysis and the Pathophysiology of Sickle Cell Disease
Gregory Kato, Martin H. Steinberg, Mark Gladwin
Journal of Clinical Investigation 2017
Functional and anatomical evidence of cerebral tissue hypoxia in young sickle cell anemia mice
LS Cahill, LM Gazdzinski, AK Tsui, YQ Zhou, S Portnoy, E Liu, CD Mazer, GM Hare, A Kassner, JG Sled
Journal of Cerebral Blood Flow & Metabolism 2017
Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung
BY Kang, K Park, JM Kleinhenz, TC Murphy, RL Sutliff, D Archer, CM Hart
American journal of respiratory cell and molecular biology 2017
Triggers, Inhibitors, Mechanisms, and Significance of Eryptosis: The Suicidal Erythrocyte Death
E Lang, F Lang
BioMed Research International 2015
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease
JA Detterich, RM Kato, M Rabai, HJ Meiselman, TD Coates, JC Wood
Blood 2015
A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia: A GCH1 haplotype confers sex-specific susceptibility
I Belfer, V Youngblood, DS Darbari, Z Wang, L Diaw, L Freeman, K Desai, M Dizon, D Allen, C Cunnington, KM Channon, J Milton, SW Hartley, V Nolan, GJ Kato, MH Steinberg, D Goldman, JG VI
American Journal of Hematology 2014
Sickle erythrocytes and platelets augment lung leukotriene synthesis with downregulation of anti-inflammatory proteins: relevance in the pathology of the acute chest syndrome
M Opene, J Kurantsin-Mills, S Husain, BO Ibe
Pulmonary circulation 2014
Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease
EM Novelli, M Hildesheim, C Rosano, R Vanderpool, M Simon, GJ Kato, MT Gladwin, D Guerrot
PloS one 2014
Vasculopathy and pulmonary hypertension in sickle cell disease
KP Potoka, MT Gladwin
American journal of physiology. Lung cellular and molecular physiology 2014
Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease
AM Gorbach, HC Ackerman, WM Liu, JM Meyer, PL Littel, C Seamon, E Footman, A Chi, S Zorca, ML Krajewski, MJ Cuttica, RF Machado, RO 3rd, GJ Kato
Microvascular Research 2012
Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis
B Musicki, T Liu, SF Sezen, AL Burnett
The Journal of Sexual Medicine 2012
Association of Inflammatory Biomarker C-Reactive Protein, Lipid Peroxidation and Antioxidant Capacity Marker with HbF Level in Sickle Cell Disease Patients from Chattisgarh
S Bhagat, PK Patra, AS Thakur
Indian Journal of Clinical Biochemistry 2012
Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications
DK Kaul, ME Fabry, SM Suzuka, X Zhang
American journal of physiology. Heart and circulatory physiology 2012
Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
EJ van Beers, GJ Kato
Revista Brasileira de Hematologia e Hemoterapia 2012
Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis
P Deonikar, M Kavdia
Journal of applied physiology 2012
Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy: TRANSFUSION WORSENS RBC OXYGEN TRANSPORT
J Detterich, T Alexy, M Rabai, R Wenby, A Dongelyan, T Coates, J Wood, H Meiselman
Transfusion 2012
NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease: NT-proBNP and the Risk of Death in the CSSCD
RF Machado, M Hildesheim, L Mendelsohn, AT Remaley, GJ Kato, MT Gladwin
British Journal of Haematology 2011
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: A randomized clinical trial
Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, Hagar RW, Howard T, Nuss R, Okam MM, Tremonti CK, Berman B, Villella A, Krishnamurti L, Lanzkron S, Castro O, Gordeuk VR, Coles WA, Peters-Lawrence M, Nichols J, Hall MK, Hildesheim M, Blackwelder WC, Baldassarre J, Casella JF
Journal of the American Medical Association 2011
Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia
CS Cho, GJ Kato, SH Yang, SW Bae, JS Lee, MT Gladwin, SG Rhee
Antioxidants & Redox Signaling 2010
Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue
ND Kanika, A Melman, KP Davies
International Journal of Impotence Research 2010
Pulmonary hypertension and NO in sickle cell
MT Gladwin, RJ Barst, OL Castro, VR Gordeuk, CA Hillery, GJ Kato, DB Kim-Shapiro, R Machado, CR Morris, MH Steinberg, EP Vichinsky
Blood 2010
Sickle red cell-endothelium interactions
DK Kaul, E Finnegan, GA Barabino
Microcirculation (New York, N.Y. : 1994) 2009
Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice
T Dasgupta, ME Fabry, DK Kaul
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2009
Red blood cells induce hypoxic lung inflammation
R Kiefmann, JM Rifkind, E Nagababu, J Bhattacharya
Blood 2008
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress
DK Kaul, X Zhang, T Dasgupta, ME Fabry
American journal of physiology. Heart and circulatory physiology 2008
Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis
PC Minneci, KJ Deans, S Shiva, H Zhi, SM Banks, S Kern, C Natanson, SB Solomon, MT Gladwin
American journal of physiology. Heart and circulatory physiology 2008
Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study
AK Mack, VR McGowan, CK Tremonti, D Ackah, C Barnett, RF Machado, MT Gladwin, GJ Kato
British Journal of Haematology 2008
The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology
ML Krajewski, LL Hsu, MT Gladwin
American journal of physiology. Heart and circulatory physiology 2008
Morphological and functional platelet abnormalities in Berkeley sickle cell mice
AS Shet, TJ Hoffmann, M Jirouskova, CA Janczak, JR Stevens, A Adamson, N Mohandas, EA Manci, T Cynober, BS Coller
Blood Cells, Molecules, and Diseases 2008
Alpha-hemoglobin-stabilizing protein (AHSP) in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome, intrauterine growth restriction (IUGR) and fetal death
M Emanuelli, D Sartini, V Rossi, A Corradetti, B Landi, CR Vianna, S Giannubilo, AL Tranquilli
Cell Stress and Chaperones 2008
Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.
Morris CR, Gladwin MT, Kato GJ
Current molecular medicine 2008
C-Reactive Protein and Interleukin-6 Are Decreased in Transgenic Sickle Cell Mice Fed a High Protein Diet,
Archer DR, Stiles JK, Newman GW, Quarshie A, Hsu LL, Sayavongsa P, Perry J, Jackson EM, Hibbert JM
The Journal of nutrition 2008
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability
LL Hsu, HC Champion, SA Campbell-Lee, TJ Bivalacqua, EA Manci, BA Diwan, DM Schimel, AE Cochard, X Wang, AN Schechter, CT Noguchi, MT Gladwin
Blood 2007
Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2
GD Ferguson, K Jensen-Pergakes, C Wilkey, U Jhaveri, N Richard, D Verhelle, LM Parseval, LG Corral, W Xie, CL Morris, H Brady, K Chan
Journal of Clinical Immunology 2007
Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency
VR Gordeuk, V Sachdev, JG Taylor, MT Gladwin, G Kato, OL Castro
American Journal of Hematology 2007
Deconstructing endothelial dysfunction: guanylyl cyclase oxidation and the NO resistance syndrome
Mark T. Gladwin
Journal of Clinical Investigation 2006
Protective effect of arginine on oxidative stress in transgenic sickle mouse models
T Dasgupta, RP Hebbel, DK Kaul
Free radical biology & medicine 2006
Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease
RF Machado, AK Mack, S Martyr, C Barnett, P Macarthur, V Sachdev, I Ernst, LA Hunter, WA Coles, JP Nichols, GJ Kato, MT Gladwin
British Journal of Haematology 2006
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease
GJ Kato, V McGowan, RF Machado, JA Little, J Taylor, CR Morris, JS Nichols, X Wang, M Poljakovic, SM Morris, MT Gladwin
Blood 2006
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin
Peter C. Minneci, Katherine J. Deans, Huang Zhi, Peter S.T. Yuen, Robert A. Star, Steven M Banks, Alan N. Schechter, Charles Natanson, Mark T Gladwin, Steven B Solomon
Journal of Clinical Investigation 2005
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease
CR Morris, GJ Kato, M Poljakovic, X Wang, WC Blackwelder, V Sachdev, SL Hazen, EP Vichinsky, SM Morris, MT Gladwin
JAMA : the journal of the American Medical Association 2005
Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia
MT Gladwin, GJ Kato
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2005

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
16 readers on Mendeley
See more details